Skip to main content
. 2021 Jun 1;32(6):1305–1317. doi: 10.1681/ASN.2021010039

Table 1.

Overview of work phases and activities of the NKF-ASN Task Force

Phase One Phase Two Phase Three
Clarifying the problem and evidence Evaluating the approaches Making recommendations
 eGFR and measurement  Clinical consequences of different approaches  Issuance of recommendations
Race, racism, and genetic ancestry.  System and societal consequences of different approaches  Comment on recommendations
 Body composition and populations used in GFR estimation  Implementation
 Standardization and guidelines
 Patients’ perspective and shared decision making
Possible approaches to address race in GFR estimation (Table 4)